Every 424B that HCA Healthcare, Inc. (HCA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow HCA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCA filings page.
HCA Inc. is offering $3,000,000,000 aggregate principal amount of senior notes: $1,000,000,000 4.700% notes due May 15, 2031, $750,000,000 5.000% notes due May 15, 2033, and $1,250,000,000 5.300% notes due May 15, 2036. Interest on each series is payable semi‑annually on May 15 and November 15, beginning November 15, 2026.
HCA intends to use net proceeds (estimated at $2.975 billion) to redeem in full its outstanding $1.500 billion 5.250% notes due June 2026 and $1.000 billion 5.375% notes due September 2026 and for general corporate purposes, which may include repayment of commercial paper. The notes are senior unsecured obligations of HCA Inc. and are guaranteed on a senior unsecured basis by HCA Healthcare, Inc.
HCA Inc. is offering multiple series of senior notes, each to be fully and unconditionally guaranteed on a senior unsecured basis by parent HCA Healthcare, Inc. The prospectus supplement states interest will be paid semi‑annually and the notes may be redeemed optionally; a Change of Control Triggering Event would permit holders to require repurchase at 101% plus accrued interest. Net proceeds are intended for general corporate purposes and may be used to repay commercial paper and to redeem some or all of the $1.500 billion 5.250% notes due June 2026 and the $1.000 billion 5.375% notes due September 2026. The document also discloses first quarter 2026 operating results: revenues of $19.109 billion, net income attributable to HCA Healthcare, Inc. of $1.620 billion and Adjusted EBITDA of $3.802 billion.
HCA Inc. launched a primary offering of $3.25 billion senior notes across four tranches: $500 million 4.300% due 2030, $1.0 billion 4.600% due 2032, $1.0 billion 4.900% due 2035, and $750 million 5.700% due 2055. Interest is paid semi‑annually beginning May 15, 2026, with stated maturities on November 15 of each respective year.
The notes are senior unsecured obligations of HCA Inc., fully and unconditionally guaranteed on a senior unsecured basis by HCA Healthcare, Inc., and structurally subordinated to subsidiary debt. HCA may redeem the notes at the specified make‑whole premiums prior to each series’ par call date, and at par thereafter; a Change of Control Triggering Event requires a 101% repurchase offer.
HCA expects net proceeds of approximately $3.218 billion, to be used to redeem all $1.5 billion of 5.875% senior notes due 2026 and for general corporate purposes, which may include repaying commercial paper. Recent results noted revenues of $56.087 billion and Adjusted EBITDA of $11.452 billion for the nine months ended September 30, 2025.